Paper36060733
In silico analysis reveals the co-existence of CRISPR-Cas type I-F1 and type I-F2 systems and its association with restricted phage invasion in Acinetobacter baumannii.
Yadav G and 1 other. Front Microbiol, 2022. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. In silico analysis reveals the co-existence of CRISPR-Cas type I-F1 and type I-F2 systems and its association with restricted phage invasion in Acinetobacter baumannii. Papers, record 36060733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36060733
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In silico analysis reveals the co-existence of CRISPR-Cas type I-F1 and type I-F2 systems and its association with restricted phage invasion in Acinetobacter baumannii.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32983122 | Evolutionary Approaches to Combat Antibiotic Resistance: Opportunities and Challenges for Precision Medicine. | Front Immunol | 2020 | https://conductscience.org/library/papers/32983122 | PubMed |
| 2 | 15608208 | VFDB: a reference database for bacterial virulence factors. | Nucleic Acids Res | 2005 | https://conductscience.org/library/papers/15608208 | PubMed |
| 3 | 24086164 | Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. | PLoS Genet | 2013 | https://conductscience.org/library/papers/24086164 | PubMed |
| 4 | 26411297 | An updated evolutionary classification of CRISPR-Cas systems. | Nat Rev Microbiol | 2015 | https://conductscience.org/library/papers/26411297 | PubMed |
| 5 | 30156569 | Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria. | Curr Opin Crit Care | 2018 | https://conductscience.org/library/papers/30156569 | PubMed |
| 6 | 21552286 | Evolution and classification of the CRISPR-Cas systems. | Nat Rev Microbiol | 2011 | https://conductscience.org/library/papers/21552286 | PubMed |
| 7 | 33574807 | Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33574807 | PubMed |
| 8 | 26837824 | Major bacterial lineages are essentially devoid of CRISPR-Cas viral defence systems. | Nat Commun | 2016 | https://conductscience.org/library/papers/26837824 | PubMed |
| 9 | 32572116 | Mapping CRISPR spaceromes reveals vast host-specific viromes of prokaryotes. | Commun Biol | 2020 | https://conductscience.org/library/papers/32572116 | PubMed |
| 10 | 33270901 | RefSeq: expanding the Prokaryotic Genome Annotation Pipeline reach with protein family model curation. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33270901 | PubMed |
| 11 | 28826484 | Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems. | Elife | 2017 | https://conductscience.org/library/papers/28826484 | PubMed |
| 12 | 21143983 | BIGSdb: Scalable analysis of bacterial genome variation at the population level. | BMC Bioinformatics | 2010 | https://conductscience.org/library/papers/21143983 | PubMed |
| 13 | 31626589 | Pangenome of Acinetobacter baumannii uncovers two groups of genomes, one of them with genes involved in CRISPR/Cas defence systems associated with the absence of plasmids and exclusive genes for biofilm formation. | Microb Genom | 2019 | https://conductscience.org/library/papers/31626589 | PubMed |
| 14 | 29902258 | CRISPR-Cas antimicrobials: Challenges and future prospects. | PLoS Pathog | 2018 | https://conductscience.org/library/papers/29902258 | PubMed |
| 15 | 29036676 | Anti-CRISPRdb: a comprehensive online resource for anti-CRISPR proteins. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29036676 | PubMed |
| 16 | 26604259 | Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa. | mBio | 2015 | https://conductscience.org/library/papers/26604259 | PubMed |
| 17 | 17577412 | CRISPR recognition tool (CRT): a tool for automatic detection of clustered regularly interspaced palindromic repeats. | BMC Bioinformatics | 2007 | https://conductscience.org/library/papers/17577412 | PubMed |
| 18 | 33668622 | Genomic and Phenotypic Analysis of Multidrug-Resistant Acinetobacter baumannii Clinical Isolates Carrying Different Types of CRISPR/Cas Systems. | Pathogens | 2021 | https://conductscience.org/library/papers/33668622 | PubMed |
| 19 | 32999368 | Genomic analysis reveals high virulence and antibiotic resistance amongst phage susceptible Acinetobacter baumannii. | Sci Rep | 2020 | https://conductscience.org/library/papers/32999368 | PubMed |
| 20 | 15799709 | Evolutionary origins of genomic repertoires in bacteria. | PLoS Biol | 2005 | https://conductscience.org/library/papers/15799709 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42406312 | Genomic landscape of 340 virulent Acinetobacter bacteriophages reveals anti-CRISPR-enriched candidates for therapeutic prioritization. | Eur J Clin Microbiol Infect Dis | 2026 | https://conductscience.org/library/papers/42406312 | PubMed |
| 41892443 | Revisiting the Fight Against Acinetobacter baumannii: Emerging Non-Antibiotic Strategies. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/41892443 | PubMed |
| 41761908 | Structural basis of Cas8-independent Cas3 recruitment in Type I-F2 CRISPR-Cas. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/41761908 | PubMed |
| 41269653 | Comprehensive in silico analysis of Acinetobacter isolates from South Korea reveals genomic diversity, antimicrobial resistance, virulence factors, and evolutionary dynamics. | Genes Genomics | 2026 | https://conductscience.org/library/papers/41269653 | PubMed |
| 41170849 | BaeR and H-NS control CRISPR-Cas-mediated immunity and virulence in Acinetobacter baumannii. | mSystems | 2025 | https://conductscience.org/library/papers/41170849 | PubMed |
| 40377313 | In silico and in vitro comparative analysis of 79 Acinetobacter baumannii clinical isolates. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/40377313 | PubMed |
| 39908088 | Whole-genome sequencing of Acinetobacter baumannii clinical isolates from a tertiary hospital in Terengganu, Malaysia (2011-2020), revealed the predominance of the Global Clone 2 lineage. | Microb Genom | 2025 | https://conductscience.org/library/papers/39908088 | PubMed |
| 38655087 | A bioinformatic approach to identify confirmed and probable CRISPR-Cas systems in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex genomes. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38655087 | PubMed |
| 37513832 | CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37513832 | PubMed |
| 37094126 | Mechanistic insights into DNA binding and cleavage by a compact type I-F CRISPR-Cas system in bacteriophage. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37094126 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36060733
GET https://conductscience.org/api/papers/v1/36060733/references?page=2